Table 4 Clinical and laboratorial variables between survivors and non survivors

Age (years)

8.09 ± 4.20

4.51 ± 1.04

< 0.05

Duration of hospital stay (days)

3.43 ± 1.72

5.16 ± 1.78

< 0.05

Time to presentation (hours)

5.91 ± 3. 05

8.66 ± 3.32

< 0.05

Glasgow coma scale

9.74 ± 1.26

7.50 ± 0.83

< 0.001

Need for mechanical ventilation

9/102 (8.8%)

5/6 (83. 3%)

< 0.001

Start treatment before arrival

26 (25.5%)

0/6 (0%)

< 0.001

 Malathion (81 cases)

78 (96. 3%)

2 (3.7%)

< 0.001

 Chlorpyrifos (9 cases)

7 (77.8%)

2 (22. 2%)

 Diazinon (6 cases)

5 (83. 3%)

1 (17.7%)

 Unknown (12 cases)

11 (91.6%)

1 (8.4%)

Hemoglobin, g/dL

9.99 ± 1.59

9.56 ± 1.67

NS

Leucocytes, × 10³/mL

10.32 ± 3.09

14.66± 3.14

< 0.01

Platelets × 10³/mL

308.35 ± 89.98

340.88 ± 74. 61

NS

PaO2 mmHg

97.23 ± 11.31

83.33 ± 4.41

< 0.01

PaCO2 mmHg

40.18± 3.86

40.66 ± 4.27

NS

Cumulative dose of atropine (mg)

1.31 ± 0.52

1.61 ± 0.44

NS

Cumulative dose of pralidoxime (gm)

9.65 ± 3.68

17.4 ± 2.70

< 0.01